share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

週三盤後交易時段，12只醫療保健類股走勢
Benzinga Real-time News ·  2022/09/14 17:36

Gainers

贏家

  • Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.
  • Sonnet BioTherapeutics (NASDAQ:SONN) stock increased by 25.58% to $0.27. Trading volume for this security closed at 8.2 million, accounting for 1511.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.3 million.
  • Novo Integrated Sciences (NASDAQ:NVOS) stock rose 16.66% to $1.19. The company's market cap stands at $36.9 million.
  • HTG Molecular Diagnostics (NASDAQ:HTGM) stock increased by 14.49% to $0.87. Trading volume for this security closed at 313.3K, accounting for 9.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.6 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares moved upwards by 14.47% to $0.41. Today's trading volume for this security ended up closing at 1.4 million shares, which is 100.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $15.8 million.
  • Kodiak Sciences (NASDAQ:KOD) shares rose 9.42% to $10.1. The market value of their outstanding shares is at $525.6 million.
  • 伊諾契生物科學納斯達克(Sequoia Capital：ENOB)週三盤後上漲27.8%，至2.3美元。他們流通股的市值為1.217億美元。
  • 十四行詩生物治療學(納斯達克代碼：SONN)股價上漲25.58%，至0.27美元。這只證券的成交量為820萬只，佔過去100日全天平均成交量的1511.7。他們流通股的市值為1,630萬美元。
  • Novo集成科學納斯達克(Youku)股價上漲16.66%，至1.19美元。該公司的市值為3690萬美元。
  • HTG分子診斷學納斯達克(Tmall：HTGM)股價上漲14.49%，至0.87美元。這只證券的成交量收於313.3K，佔其過去100天全天平均成交量的9.0%。他們流通股的市值為960萬美元。
  • Ensysce生物科學納斯達克(Sequoia Capital：ENSC)股價上漲14.47%至0.41美元。該證券今日成交量為140,000股，是過去100日平均成交量的100.2%。他們流通股的市值為1,580萬美元。
  • 科迪亞克科學納斯達克(Tmall：KOD)股價上漲9.42%，至10.1美元。他們流通股的市值為5.256億美元。

Losers

失敗者

  • Eloxx Pharmaceuticals (NASDAQ:ELOX) stock decreased by 48.6% to $0.2 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 444.0K shares, which is 215.0 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $16.9 million.
  • Moleculin Biotech (NASDAQ:MBRX) stock decreased by 11.27% to $1.26. The company's market cap stands at $36.0 million.
  • IDEAYA Biosciences (NASDAQ:IDYA) shares declined by 11.12% to $11.12. IDEAYA Biosciences's trading volume hit 55.2K shares by close, accounting for 14.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $437.0 million.
  • Rhythm Pharmaceuticals (NASDAQ:RYTM) shares declined by 11.05% to $27.44. Rhythm Pharmaceuticals's trading volume hit 162.9K shares by close, accounting for 6.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.3 billion.
  • Avenue Therapeutics (NASDAQ:ATXI) stock decreased by 7.44% to $0.33. Today's trading volume for this security ended up closing at 456.5K shares, which is 146.6 percent of its average volume over the last 100 days. The company's market cap stands at $7.2 million.
  • Minerva Neurosciences (NASDAQ:NERV) shares fell 6.82% to $9.3. The market value of their outstanding shares is at $49.6 million. See Also:
  • 埃洛克斯製藥公司納斯達克(Tmall：ELOX)週三盤後下跌48.6%，至0.2美元。該證券今日成交量為444.0K股，是過去100日平均成交量的215.0%。他們流通股的市值為1690萬美元。
  • Moleclin生物技術(納斯達克：MBRX)股票下跌11.27%，至1.26美元。該公司的市值為3,600萬美元。
  • 艾迪亞生物科學(納斯達克代碼：IDYA)股價下跌11.12%，至11.12美元。截至收盤，IDEAYA Biosciences的成交量達到55.2萬股，佔其過去100天平均成交量的14.4%。他們流通股的市值為4.37億美元。
  • 節奏製藥公司納斯達克(Tmall：RYTM)股價下跌11.05%，至27.44美元。節奏製藥收盤時成交量達到162.9萬股，佔其過去100個交易日平均成交量的6.5%。他們流通股的市值為13億美元。
  • 大道治療公司納斯達克股票代碼：ATXI)股價下跌7.44%，至0.33美元。該證券今日成交量為456.5K股，是過去100日平均成交量的146.6%。該公司的市值為720萬美元。
  • 密涅瓦神經科學納斯達克股價下跌6.82%，至9.3美元。他們流通股的市值為4960萬美元。另見：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由benzinga的自動內容引擎生成，並由編輯審閱.

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論